3351 - 3360 of 8571 Results
Title
Year
- Parkinson’s Patients’ Tolerance for Risk and Willingness to Wait for Potential Benefits of Novel Neurostimulation Devices: A Patient-Centered Threshold Technique Study2021OPENTitle: Parkinson’s Patients’ Tolerance for Risk and Willingness to Wait for Potential Benefits of Novel Neurostimulation Devices: A Patient-Centered Threshold Technique StudyJournal Name: MDM Policy & PracticePublisher: SAGE PublicationsVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/2381468320978407Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/2381468320978407Citation Count: 22
-
RESTRICTEDTitle: Detecting Sensitive Mobility Features for Parkinson's Disease Stages Via Machine LearningJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 9Start Page: 2144End Page: 2155Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28631Citation Count: 60
-
OPENTitle: Neuroimaging-based data-driven subtypes of spatiotemporal atrophy due to Parkinson’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaf146Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcaf146/62941156/fcaf146.pdfCitation Count: 0
- Expression, purification and preliminary biochemical and structural characterization of the leucine rich repeat namesake domain of leucine rich repeat kinase 22012RESTRICTEDTitle: Expression, purification and preliminary biochemical and structural characterization of the leucine rich repeat namesake domain of leucine rich repeat kinase 2Journal Name: Biochimica et Biophysica Acta (BBA) - Proteins and ProteomicsPublisher: Elsevier BVVol: 1824Issue #: 3Start Page: 450End Page: 460Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bbapap.2011.12.009Citation Count: 26
- Identification of Parkinson’s disease PACE subtypes and repurposing treatments through integrative analyses of multimodal data2024OPENTitle: Identification of Parkinson’s disease PACE subtypes and repurposing treatments through integrative analyses of multimodal dataJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-024-01175-9Best OA location URL: https://www.nature.com/articles/s41746-024-01175-9.pdfCitation Count: 12
-
OPENTitle: The effect of LRRK2 loss-of-function variants in humansJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 26Issue #: 6Start Page: 869End Page: 877Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41591-020-0893-5Best OA location URL: https://www.nature.com/articles/s41591-020-0893-5.pdfCitation Count: 103
- Structural and Functional Impact of Parkinson Disease-Associated Mutations in the E3 Ubiquitin Ligase Parkin2015OPENTitle: Structural and Functional Impact of Parkinson Disease-Associated Mutations in the E3 Ubiquitin Ligase ParkinJournal Name: Human MutationPublisher: WileyVol: 36Issue #: 8Start Page: 774End Page: 786Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/humu.22808Citation Count: 84
- Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson’s Disease2016OPENTitle: Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2016.00271Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2016.00271/pdfCitation Count: 7
- The Alzheimer's disease‐associated C99 fragment of APP regulates cellular cholesterol trafficking2020OPENTitle: The Alzheimer's disease‐associated C99 fragment of APP regulates cellular cholesterol traffickingJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 39Issue #: 20Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/embj.2019103791Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.15252/embj.2019103791Citation Count: 107
- MHCII reduction is insufficient to protect mice from alpha-synuclein-induced degeneration and the Parkinson’s HLA locus exhibits epigenetic regulation2025OPENTitle: MHCII reduction is insufficient to protect mice from alpha-synuclein-induced degeneration and the Parkinson’s HLA locus exhibits epigenetic regulationJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-025-95679-3Best OA location URL: https://www.nature.com/articles/s41598-025-95679-3.pdfCitation Count: 0